Thorne HealthTech Reports Fourth Quarter and Full-Year 2022 Results
Provided By PR Newswire
Last update: Mar 30, 2023
Net Sales Growth of 24.1% and Adj. EBITDA1 growth of 19.1% for Full-Year 2022; Provides Full-Year 2023 Guidance
NEW YORK, March 30, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, today announced its financial results for the fourth quarter and full-year ended December 31, 2022.
Read more at prnewswire.com
